jeffy john

• Responsible for histopathology reporting and molecular pathology workflows
• Supervising immunohistochemistry and molecular testing sections
• Overseeing oncopathology diagnostics and interdepartmental quality control
• Lead and manage histopathology, molecular pathology and molecular infectious/HPV section
operations, overseeing quality documentation for CAP/NABL/ISO compliance
• Develop and implement comprehensive SOPs, risk assessments, and emergency response plans for
laboratory operations as Lab safety officer
• Drive commercial strategies for client acquisition and optimize sample collection workflows
• Contribute to precision oncology through molecular tumor board discussions and somatic variant
interpretation
• Analyze complex diagnostic cases including molecular pathology interpretations and research data
from multi-center studies

• Reporting wide spectrum of surgical pathology and cytology cases
• Active involvement in multidisciplinary tumor board discussions
• Participation in molecular oncology and precision diagnostics
• Led the molecular oncology wing (ACTIMOS), advancing precision oncology capabilities in the region
• Performed routine Histopathology reporting, immunohistochemistry procedures and delivered detailed,
accurate diagnostic reports
• Played a pivotal role in achieving NABL accreditation for the Histopathology department, ensuring
compliance with stringent quality standards
• Maintained and calibrated laboratory equipment for histopathology, IHC, and molecular studies
• Interpreted complex genetic data to support patient management in clinical and diagnostic settings

• Successfully issued the first diagnostic NGS report in Kerala, pioneering molecular diagnostics in
the region
• Introduced comprehensive molecular testing portfolio including RT-PCR, MLPA, and Gene
Sequencing (NGS)
• Launched first-in-Kerala companion diagnostics: PD-L1, ALK D5F3, and BRAF for targeted
cancer therapy
• Introduced EGFR liquid biopsy testing for the first time in Kerala
• Established oncology molecular tests: EGFR, JAK2, MPN Panel, BCR-ABL, and DPYD mutations
• Expanded non-oncology molecular diagnostics: Y-Chromosome Microdeletions, Antenatal
Chromosome Testing, HLA-B27
• Implemented complex genetic testing via NGS: Tumor Hotspot Mutation Panel, BRCA, and
Hereditary Mutation Panel
• Actively contributed to successful NABL accreditation of one of the earliest NGS capable
molecular genetics laboratories in Kerala
• Demonstrated leadership excellence while heading the molecular genetics laboratory